Biotech

All Articles

J &amp J goes down phase 2 dengue prospect in most recent shift from injections

.Johnson &amp Johnson's deprioritization of its own contagious health condition pipeline has profess...

Relay sheds 10% of staff after earlier cutbacks in July

.Precision medicine biotech Relay Rehabs is dropping approximately 10% of its own staff in attempts ...

Pentixapharm scores $22M IPO to allowance radiopharma tests

.Pentixapharm has produced just about twenty thousand europeans ($ 22 million) from an IPO, with the...

Lundbeck taps Charles River for AI-enabled neuro medication discovery

.Lundbeck has used Charles Waterway Laboratories' artificial intelligence functionalities to assist ...

Big pharma, biotech 'will not necessarily be actually symbiotic' in AI: S&ampP

.Huge Pharma is putting in intensely in AI to slash progression timelines as well as foster advancem...

I &amp I biotech Triveni increases $115M for preclinical antibodies

.Triveni Bio has roped in $115 thousand in collection B funds to advance preclinical antibody progra...

IGM rotates from cancer to autoimmune, shocking C-suite

.IGM Biosciences finished in 2013 laying off staff and also enhancing its cancer cells pipeline. Rig...

Shattuck centers CD47 plan over weak efficacy data, gives up 40% of workers and also sheds Ono handle

.Shattuck Labs has actually hammered yet another nail right into the casket of CD47. After seeing a ...

BioMarin goes Backpacking, striking RNA deal with biotech

.BioMarin is incorporating firewood to the R&ampD fire, hitting a suit along with CAMP4 Rehabs for c...

Cash- strapped Gritstone begins search for critical alternatives as cancer injection data underwhelm

.Gritstone biography has generated lenders to explore "potential value-maximizing strategies" after ...